IDEX Corporation
IDEX Corporation (IEX) Financial Performance & Income Statement Overview
Review IDEX Corporation (IEX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
IDEX Corporation (IEX) Income Statement & Financial Overview
Explore comprehensive income reports for IDEX Corporation IEX, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $865.40M | $814.30M | $862.90M | $798.20M |
| Cost of Revenue | $473.20M | $445.40M | $495.80M | $444.30M |
| Gross Profit | $392.20M | $368.90M | $367.10M | $353.90M |
| Gross Profit Ratio | $0.45 | $0.45 | $0.43 | $0.44 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $203.60M | $209.40M | $197.90M | $177.40M |
| Operating Expenses | $203.60M | $208.70M | $201.70M | $182.90M |
| Total Costs & Expenses | $676.80M | $672.30M | $697.60M | $627.20M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $15.60M | $16.10M | $16.70M | $10.30M |
| Depreciation & Amortization | -$1.40M | $1.40M | $50.70M | $43.90M |
| EBITDA | $184.60M | $142.00M | $218.60M | $208.60M |
| EBITDA Ratio | $0.21 | $0.17 | $0.25 | $0.26 |
| Operating Income | $187.90M | $142.00M | $165.30M | $168.00M |
| Operating Income Ratio | $0.22 | $0.17 | $0.19 | $0.21 |
| Other Income/Expenses (Net) | -$18.00M | -$17.50M | -$14.10M | -$13.60M |
| Income Before Tax | $169.90M | $124.50M | $151.20M | $154.40M |
| Income Before Tax Ratio | $0.20 | $0.15 | $0.18 | $0.19 |
| Income Tax Expense | $38.80M | $29.10M | $28.00M | $35.50M |
| Net Income | $131.60M | $95.50M | $123.20M | $119.10M |
| Net Income Ratio | $0.15 | $0.12 | $0.14 | $0.15 |
| EPS | $1.74 | $1.26 | $1.62 | $1.57 |
| Diluted EPS | $1.74 | $1.26 | $1.62 | $1.57 |
| Weighted Avg Shares Outstanding | $75.60M | $75.70M | $75.80M | $75.70M |
| Weighted Avg Shares Outstanding (Diluted) | $75.70M | $75.80M | $75.90M | $75.90M |
Over the past four quarters, IDEX Corporation demonstrated steady revenue growth, increasing from $798.20M in Q3 2024 to $865.40M in Q2 2025. Operating income reached $187.90M in Q2 2025, maintaining a consistent 22% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $184.60M, reflecting operational efficiency. Net income rose to $131.60M, with EPS at $1.74. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan